CompletedNCT04032301
Ketamine as a Research Tool for PTSD and Depression in Veterans
About this title
Read the official source — NCT04032301Medication studyAges 18–75United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 75 years.
- Listed locations
- MinneapolisSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Study information
Study start dateStarted: September 30, 2019
- Recruitment status
- Completed
- Enrollment listed in the registry
- 67
- Sponsor
- University of Minnesota
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug, Other
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- From 18 Years to 75 Years
- Official registry ID
- NCT04032301
- Official title
Show the full official title
Characterization of Comorbid Post-traumatic Stress Disorder and Major Depressive Disorder Utilizing Ketamine as an Experimental Medicine Probe
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Minneapolis
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Minnesota, a university.
Did this study involve medication?
Yes. The study involved medication, including ketamine.
Who was this study for?
Listed age limits: 18 years to 75 years.
